nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2C8—Mometasone—systemic scleroderma	0.306	0.468	CbGbCtD
Sulfadiazine—CYP2C9—Leflunomide—systemic scleroderma	0.138	0.21	CbGbCtD
Sulfadiazine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.122	0.186	CbGbCtD
Sulfadiazine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0494	0.0755	CbGbCtD
Sulfadiazine—CYP3A4—Prednisone—systemic scleroderma	0.0395	0.0604	CbGbCtD
Sulfadiazine—CYP2C9—cardial valve—systemic scleroderma	0.0038	0.84	CbGeAlD
Sulfadiazine—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00115	0.00336	CcSEcCtD
Sulfadiazine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00114	0.00335	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00114	0.00334	CcSEcCtD
Sulfadiazine—Stomatitis—Mycophenolic acid—systemic scleroderma	0.00114	0.00334	CcSEcCtD
Sulfadiazine—Insomnia—Pentoxifylline—systemic scleroderma	0.00113	0.00332	CcSEcCtD
Sulfadiazine—Arthralgia—Mometasone—systemic scleroderma	0.00113	0.0033	CcSEcCtD
Sulfadiazine—Erythema multiforme—Azathioprine—systemic scleroderma	0.0011	0.00323	CcSEcCtD
Sulfadiazine—Hepatitis—Leflunomide—systemic scleroderma	0.0011	0.00322	CcSEcCtD
Sulfadiazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00109	0.0032	CcSEcCtD
Sulfadiazine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00109	0.00319	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00108	0.00316	CcSEcCtD
Sulfadiazine—Skin exfoliation—Prednisone—systemic scleroderma	0.00107	0.00313	CcSEcCtD
Sulfadiazine—Depression—Lisinopril—systemic scleroderma	0.00105	0.00308	CcSEcCtD
Sulfadiazine—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00105	0.00307	CcSEcCtD
Sulfadiazine—Chills—Azathioprine—systemic scleroderma	0.00105	0.00306	CcSEcCtD
Sulfadiazine—Hallucination—Mycophenolic acid—systemic scleroderma	0.00104	0.00306	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00104	0.00306	CcSEcCtD
Sulfadiazine—Erythema multiforme—Leflunomide—systemic scleroderma	0.00104	0.00305	CcSEcCtD
Sulfadiazine—Skin discolouration—Methotrexate—systemic scleroderma	0.00103	0.00303	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00103	0.00302	CcSEcCtD
Sulfadiazine—Anorexia—Mometasone—systemic scleroderma	0.00103	0.00301	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00102	0.003	CcSEcCtD
Sulfadiazine—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00297	CcSEcCtD
Sulfadiazine—Oliguria—Methotrexate—systemic scleroderma	0.00101	0.00297	CcSEcCtD
Sulfadiazine—Urticaria—Pentoxifylline—systemic scleroderma	0.000994	0.00291	CcSEcCtD
Sulfadiazine—Arthralgia—Captopril—systemic scleroderma	0.000989	0.0029	CcSEcCtD
Sulfadiazine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000989	0.0029	CcSEcCtD
Sulfadiazine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000989	0.0029	CcSEcCtD
Sulfadiazine—Chills—Leflunomide—systemic scleroderma	0.000987	0.00289	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000984	0.00288	CcSEcCtD
Sulfadiazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.000983	0.00288	CcSEcCtD
Sulfadiazine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.000978	0.00287	CcSEcCtD
Sulfadiazine—Sepsis—Prednisone—systemic scleroderma	0.00097	0.00284	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Captopril—systemic scleroderma	0.000948	0.00278	CcSEcCtD
Sulfadiazine—Hepatitis—Lisinopril—systemic scleroderma	0.000945	0.00277	CcSEcCtD
Sulfadiazine—Chills—Mycophenolic acid—systemic scleroderma	0.000942	0.00276	CcSEcCtD
Sulfadiazine—Hallucination—Lisinopril—systemic scleroderma	0.00094	0.00276	CcSEcCtD
Sulfadiazine—Decreased appetite—Mometasone—systemic scleroderma	0.000938	0.00275	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Captopril—systemic scleroderma	0.000928	0.00272	CcSEcCtD
Sulfadiazine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000922	0.0027	CcSEcCtD
Sulfadiazine—Depression—Mycophenolate mofetil—systemic scleroderma	0.00092	0.00269	CcSEcCtD
Sulfadiazine—Leukopenia—Azathioprine—systemic scleroderma	0.000908	0.00266	CcSEcCtD
Sulfadiazine—Vascular purpura—Prednisone—systemic scleroderma	0.000907	0.00266	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000904	0.00265	CcSEcCtD
Sulfadiazine—Anorexia—Captopril—systemic scleroderma	0.000904	0.00265	CcSEcCtD
Sulfadiazine—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.000899	0.00263	CcSEcCtD
Sulfadiazine—Erythema multiforme—Lisinopril—systemic scleroderma	0.000894	0.00262	CcSEcCtD
Sulfadiazine—Skin exfoliation—Methotrexate—systemic scleroderma	0.000892	0.00261	CcSEcCtD
Sulfadiazine—Pruritus—Pentoxifylline—systemic scleroderma	0.000885	0.00259	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000883	0.00259	CcSEcCtD
Sulfadiazine—Tinnitus—Lisinopril—systemic scleroderma	0.000881	0.00258	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000877	0.00257	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000864	0.00253	CcSEcCtD
Sulfadiazine—Arthralgia—Azathioprine—systemic scleroderma	0.000863	0.00253	CcSEcCtD
Sulfadiazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000861	0.00252	CcSEcCtD
Sulfadiazine—Vertigo—Leflunomide—systemic scleroderma	0.00086	0.00252	CcSEcCtD
Sulfadiazine—Insomnia—Captopril—systemic scleroderma	0.000858	0.00251	CcSEcCtD
Sulfadiazine—Leukopenia—Leflunomide—systemic scleroderma	0.000857	0.00251	CcSEcCtD
Sulfadiazine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000856	0.00251	CcSEcCtD
Sulfadiazine—Abdominal pain—Mometasone—systemic scleroderma	0.000853	0.0025	CcSEcCtD
Sulfadiazine—Body temperature increased—Mometasone—systemic scleroderma	0.000853	0.0025	CcSEcCtD
Sulfadiazine—Chills—Lisinopril—systemic scleroderma	0.000848	0.00248	CcSEcCtD
Sulfadiazine—Purpura—Prednisone—systemic scleroderma	0.000842	0.00247	CcSEcCtD
Sulfadiazine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000828	0.00243	CcSEcCtD
Sulfadiazine—Decreased appetite—Captopril—systemic scleroderma	0.000824	0.00241	CcSEcCtD
Sulfadiazine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000824	0.00241	CcSEcCtD
Sulfadiazine—Vertigo—Mycophenolic acid—systemic scleroderma	0.000821	0.0024	CcSEcCtD
Sulfadiazine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000818	0.0024	CcSEcCtD
Sulfadiazine—Arthralgia—Leflunomide—systemic scleroderma	0.000815	0.00239	CcSEcCtD
Sulfadiazine—Sepsis—Methotrexate—systemic scleroderma	0.000811	0.00238	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00081	0.00237	CcSEcCtD
Sulfadiazine—Vomiting—Pentoxifylline—systemic scleroderma	0.000795	0.00233	CcSEcCtD
Sulfadiazine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000791	0.00232	CcSEcCtD
Sulfadiazine—Rash—Pentoxifylline—systemic scleroderma	0.000789	0.00231	CcSEcCtD
Sulfadiazine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000788	0.00231	CcSEcCtD
Sulfadiazine—Headache—Pentoxifylline—systemic scleroderma	0.000784	0.0023	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000781	0.00229	CcSEcCtD
Sulfadiazine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000778	0.00228	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000775	0.00227	CcSEcCtD
Sulfadiazine—Polyuria—Methotrexate—systemic scleroderma	0.000772	0.00226	CcSEcCtD
Sulfadiazine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000772	0.00226	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000765	0.00224	CcSEcCtD
Sulfadiazine—Pruritus—Mometasone—systemic scleroderma	0.000764	0.00224	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000754	0.00221	CcSEcCtD
Sulfadiazine—Abdominal pain—Captopril—systemic scleroderma	0.00075	0.0022	CcSEcCtD
Sulfadiazine—Body temperature increased—Captopril—systemic scleroderma	0.00075	0.0022	CcSEcCtD
Sulfadiazine—Anorexia—Leflunomide—systemic scleroderma	0.000745	0.00218	CcSEcCtD
Sulfadiazine—Nausea—Pentoxifylline—systemic scleroderma	0.000743	0.00218	CcSEcCtD
Sulfadiazine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000743	0.00218	CcSEcCtD
Sulfadiazine—Vertigo—Lisinopril—systemic scleroderma	0.000739	0.00217	CcSEcCtD
Sulfadiazine—Diarrhoea—Mometasone—systemic scleroderma	0.000739	0.00216	CcSEcCtD
Sulfadiazine—Leukopenia—Lisinopril—systemic scleroderma	0.000736	0.00216	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00073	0.00214	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000719	0.00211	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000714	0.00209	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000712	0.00209	CcSEcCtD
Sulfadiazine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000711	0.00208	CcSEcCtD
Sulfadiazine—Insomnia—Leflunomide—systemic scleroderma	0.000707	0.00207	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000701	0.00205	CcSEcCtD
Sulfadiazine—Arthralgia—Lisinopril—systemic scleroderma	0.0007	0.00205	CcSEcCtD
Sulfadiazine—Pancreatitis—Prednisone—systemic scleroderma	0.000688	0.00201	CcSEcCtD
Sulfadiazine—Vomiting—Mometasone—systemic scleroderma	0.000686	0.00201	CcSEcCtD
Sulfadiazine—Rash—Mometasone—systemic scleroderma	0.000681	0.00199	CcSEcCtD
Sulfadiazine—Dermatitis—Mometasone—systemic scleroderma	0.00068	0.00199	CcSEcCtD
Sulfadiazine—Decreased appetite—Leflunomide—systemic scleroderma	0.000679	0.00199	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000679	0.00199	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000677	0.00198	CcSEcCtD
Sulfadiazine—Headache—Mometasone—systemic scleroderma	0.000676	0.00198	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000675	0.00198	CcSEcCtD
Sulfadiazine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000674	0.00198	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000671	0.00197	CcSEcCtD
Sulfadiazine—Pruritus—Captopril—systemic scleroderma	0.000671	0.00197	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000657	0.00193	CcSEcCtD
Sulfadiazine—Body temperature increased—Azathioprine—systemic scleroderma	0.000654	0.00192	CcSEcCtD
Sulfadiazine—Abdominal pain—Azathioprine—systemic scleroderma	0.000654	0.00192	CcSEcCtD
Sulfadiazine—Diarrhoea—Captopril—systemic scleroderma	0.000649	0.0019	CcSEcCtD
Sulfadiazine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000648	0.0019	CcSEcCtD
Sulfadiazine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000648	0.0019	CcSEcCtD
Sulfadiazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000645	0.00189	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000644	0.00189	CcSEcCtD
Sulfadiazine—Nausea—Mometasone—systemic scleroderma	0.000641	0.00188	CcSEcCtD
Sulfadiazine—Anorexia—Lisinopril—systemic scleroderma	0.00064	0.00188	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000639	0.00187	CcSEcCtD
Sulfadiazine—Ataxia—Methotrexate—systemic scleroderma	0.000638	0.00187	CcSEcCtD
Sulfadiazine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000625	0.00183	CcSEcCtD
Sulfadiazine—Depression—Prednisone—systemic scleroderma	0.000623	0.00183	CcSEcCtD
Sulfadiazine—Urticaria—Leflunomide—systemic scleroderma	0.000621	0.00182	CcSEcCtD
Sulfadiazine—Abdominal pain—Leflunomide—systemic scleroderma	0.000618	0.00181	CcSEcCtD
Sulfadiazine—Body temperature increased—Leflunomide—systemic scleroderma	0.000618	0.00181	CcSEcCtD
Sulfadiazine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000614	0.0018	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000613	0.0018	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000612	0.00179	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000611	0.00179	CcSEcCtD
Sulfadiazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00061	0.00179	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00061	0.00179	CcSEcCtD
Sulfadiazine—Insomnia—Lisinopril—systemic scleroderma	0.000607	0.00178	CcSEcCtD
Sulfadiazine—Vomiting—Captopril—systemic scleroderma	0.000603	0.00177	CcSEcCtD
Sulfadiazine—Rash—Captopril—systemic scleroderma	0.000598	0.00175	CcSEcCtD
Sulfadiazine—Dermatitis—Captopril—systemic scleroderma	0.000597	0.00175	CcSEcCtD
Sulfadiazine—Headache—Captopril—systemic scleroderma	0.000594	0.00174	CcSEcCtD
Sulfadiazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000589	0.00173	CcSEcCtD
Sulfadiazine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000589	0.00173	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000588	0.00172	CcSEcCtD
Sulfadiazine—Decreased appetite—Lisinopril—systemic scleroderma	0.000584	0.00171	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00058	0.0017	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000576	0.00169	CcSEcCtD
Sulfadiazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000576	0.00169	CcSEcCtD
Sulfadiazine—Pancreatitis—Methotrexate—systemic scleroderma	0.000575	0.00168	CcSEcCtD
Sulfadiazine—Diarrhoea—Azathioprine—systemic scleroderma	0.000566	0.00166	CcSEcCtD
Sulfadiazine—Nausea—Captopril—systemic scleroderma	0.000563	0.00165	CcSEcCtD
Sulfadiazine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000561	0.00164	CcSEcCtD
Sulfadiazine—Hallucination—Prednisone—systemic scleroderma	0.000559	0.00164	CcSEcCtD
Sulfadiazine—Pruritus—Leflunomide—systemic scleroderma	0.000553	0.00162	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000549	0.00161	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000536	0.00157	CcSEcCtD
Sulfadiazine—Diarrhoea—Leflunomide—systemic scleroderma	0.000535	0.00157	CcSEcCtD
Sulfadiazine—Urticaria—Lisinopril—systemic scleroderma	0.000533	0.00156	CcSEcCtD
Sulfadiazine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000532	0.00156	CcSEcCtD
Sulfadiazine—Abdominal pain—Lisinopril—systemic scleroderma	0.000531	0.00156	CcSEcCtD
Sulfadiazine—Body temperature increased—Lisinopril—systemic scleroderma	0.000531	0.00156	CcSEcCtD
Sulfadiazine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000527	0.00155	CcSEcCtD
Sulfadiazine—Vomiting—Azathioprine—systemic scleroderma	0.000526	0.00154	CcSEcCtD
Sulfadiazine—Rash—Azathioprine—systemic scleroderma	0.000522	0.00153	CcSEcCtD
Sulfadiazine—Dermatitis—Azathioprine—systemic scleroderma	0.000521	0.00153	CcSEcCtD
Sulfadiazine—Depression—Methotrexate—systemic scleroderma	0.000521	0.00153	CcSEcCtD
Sulfadiazine—Headache—Azathioprine—systemic scleroderma	0.000518	0.00152	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000518	0.00152	CcSEcCtD
Sulfadiazine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000511	0.0015	CcSEcCtD
Sulfadiazine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00051	0.00149	CcSEcCtD
Sulfadiazine—Stomatitis—Methotrexate—systemic scleroderma	0.000509	0.00149	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000508	0.00149	CcSEcCtD
Sulfadiazine—Vomiting—Leflunomide—systemic scleroderma	0.000497	0.00146	CcSEcCtD
Sulfadiazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000495	0.00145	CcSEcCtD
Sulfadiazine—Rash—Leflunomide—systemic scleroderma	0.000493	0.00144	CcSEcCtD
Sulfadiazine—Dermatitis—Leflunomide—systemic scleroderma	0.000492	0.00144	CcSEcCtD
Sulfadiazine—Nausea—Azathioprine—systemic scleroderma	0.000492	0.00144	CcSEcCtD
Sulfadiazine—Headache—Leflunomide—systemic scleroderma	0.00049	0.00143	CcSEcCtD
Sulfadiazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000488	0.00143	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00141	CcSEcCtD
Sulfadiazine—Pruritus—Lisinopril—systemic scleroderma	0.000475	0.00139	CcSEcCtD
Sulfadiazine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000474	0.00139	CcSEcCtD
Sulfadiazine—Rash—Mycophenolic acid—systemic scleroderma	0.00047	0.00138	CcSEcCtD
Sulfadiazine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00047	0.00138	CcSEcCtD
Sulfadiazine—Hepatitis—Methotrexate—systemic scleroderma	0.000469	0.00137	CcSEcCtD
Sulfadiazine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000467	0.00137	CcSEcCtD
Sulfadiazine—Headache—Mycophenolic acid—systemic scleroderma	0.000467	0.00137	CcSEcCtD
Sulfadiazine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00136	CcSEcCtD
Sulfadiazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00136	CcSEcCtD
Sulfadiazine—Nausea—Leflunomide—systemic scleroderma	0.000464	0.00136	CcSEcCtD
Sulfadiazine—Diarrhoea—Lisinopril—systemic scleroderma	0.000459	0.00135	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000444	0.0013	CcSEcCtD
Sulfadiazine—Nausea—Mycophenolic acid—systemic scleroderma	0.000443	0.0013	CcSEcCtD
Sulfadiazine—Vertigo—Prednisone—systemic scleroderma	0.000439	0.00129	CcSEcCtD
Sulfadiazine—Tinnitus—Methotrexate—systemic scleroderma	0.000437	0.00128	CcSEcCtD
Sulfadiazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00127	CcSEcCtD
Sulfadiazine—Vomiting—Lisinopril—systemic scleroderma	0.000427	0.00125	CcSEcCtD
Sulfadiazine—Rash—Lisinopril—systemic scleroderma	0.000423	0.00124	CcSEcCtD
Sulfadiazine—Convulsion—Prednisone—systemic scleroderma	0.000423	0.00124	CcSEcCtD
Sulfadiazine—Dermatitis—Lisinopril—systemic scleroderma	0.000423	0.00124	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—systemic scleroderma	0.000421	0.00123	CcSEcCtD
Sulfadiazine—Headache—Lisinopril—systemic scleroderma	0.000421	0.00123	CcSEcCtD
Sulfadiazine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00122	CcSEcCtD
Sulfadiazine—Arthralgia—Prednisone—systemic scleroderma	0.000416	0.00122	CcSEcCtD
Sulfadiazine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000403	0.00118	CcSEcCtD
Sulfadiazine—Nausea—Lisinopril—systemic scleroderma	0.000399	0.00117	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000399	0.00117	CcSEcCtD
Sulfadiazine—Anorexia—Prednisone—systemic scleroderma	0.00038	0.00111	CcSEcCtD
Sulfadiazine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000374	0.0011	CcSEcCtD
Sulfadiazine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000371	0.00109	CcSEcCtD
Sulfadiazine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000371	0.00109	CcSEcCtD
Sulfadiazine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000369	0.00108	CcSEcCtD
Sulfadiazine—Vertigo—Methotrexate—systemic scleroderma	0.000367	0.00107	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—systemic scleroderma	0.000366	0.00107	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000363	0.00106	CcSEcCtD
Sulfadiazine—Insomnia—Prednisone—systemic scleroderma	0.000361	0.00106	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—systemic scleroderma	0.000354	0.00104	CcSEcCtD
Sulfadiazine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00102	CcSEcCtD
Sulfadiazine—Arthralgia—Methotrexate—systemic scleroderma	0.000348	0.00102	CcSEcCtD
Sulfadiazine—Decreased appetite—Prednisone—systemic scleroderma	0.000347	0.00102	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000333	0.000976	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000326	0.000956	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000326	0.000955	CcSEcCtD
Sulfadiazine—Anorexia—Methotrexate—systemic scleroderma	0.000318	0.000931	CcSEcCtD
Sulfadiazine—Urticaria—Prednisone—systemic scleroderma	0.000317	0.000928	CcSEcCtD
Sulfadiazine—Abdominal pain—Prednisone—systemic scleroderma	0.000315	0.000924	CcSEcCtD
Sulfadiazine—Body temperature increased—Prednisone—systemic scleroderma	0.000315	0.000924	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000304	0.00089	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—systemic scleroderma	0.000301	0.000883	CcSEcCtD
Sulfadiazine—Hypersensitivity—Prednisone—systemic scleroderma	0.000294	0.000861	CcSEcCtD
Sulfadiazine—Decreased appetite—Methotrexate—systemic scleroderma	0.00029	0.000849	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000288	0.000843	CcSEcCtD
Sulfadiazine—Pruritus—Prednisone—systemic scleroderma	0.000282	0.000827	CcSEcCtD
Sulfadiazine—Diarrhoea—Prednisone—systemic scleroderma	0.000273	0.000799	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000273	0.000798	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—systemic scleroderma	0.000265	0.000776	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000263	0.000772	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—systemic scleroderma	0.000263	0.000772	CcSEcCtD
Sulfadiazine—Vomiting—Prednisone—systemic scleroderma	0.000254	0.000743	CcSEcCtD
Sulfadiazine—Rash—Prednisone—systemic scleroderma	0.000251	0.000737	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisone—systemic scleroderma	0.000251	0.000736	CcSEcCtD
Sulfadiazine—Headache—Prednisone—systemic scleroderma	0.00025	0.000732	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000246	0.000719	CcSEcCtD
Sulfadiazine—Nausea—Prednisone—systemic scleroderma	0.000237	0.000694	CcSEcCtD
Sulfadiazine—Pruritus—Methotrexate—systemic scleroderma	0.000236	0.000691	CcSEcCtD
Sulfadiazine—Diarrhoea—Methotrexate—systemic scleroderma	0.000228	0.000668	CcSEcCtD
Sulfadiazine—Vomiting—Methotrexate—systemic scleroderma	0.000212	0.000621	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—systemic scleroderma	0.00021	0.000616	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—systemic scleroderma	0.00021	0.000615	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—systemic scleroderma	0.000209	0.000612	CcSEcCtD
Sulfadiazine—Nausea—Methotrexate—systemic scleroderma	0.000198	0.00058	CcSEcCtD
Sulfadiazine—CYP2C9—digestive system—systemic scleroderma	0.000164	0.0364	CbGeAlD
Sulfadiazine—CYP2E1—digestive system—systemic scleroderma	0.000156	0.0345	CbGeAlD
Sulfadiazine—CYP2E1—tendon—systemic scleroderma	0.000148	0.0328	CbGeAlD
Sulfadiazine—CYP2E1—lung—systemic scleroderma	0.00013	0.0288	CbGeAlD
Sulfadiazine—CYP3A4—digestive system—systemic scleroderma	0.000125	0.0277	CbGeAlD
